Industry
Drug Manufacturers - Specialty & Generic
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
March 22, 2024 | 3:39 pm
Portfolio Pulse from Benzinga Insights
March 21, 2024 | 9:05 pm
Portfolio Pulse from Benzinga Newsdesk
March 21, 2024 | 9:03 pm
Portfolio Pulse from Benzinga Insights
March 21, 2024 | 10:15 am
Portfolio Pulse from Benzinga Insights
March 20, 2024 | 5:01 pm
Portfolio Pulse from Benzinga Newsdesk
March 18, 2024 | 12:31 pm
Portfolio Pulse from Benzinga Newsdesk
February 16, 2024 | 1:00 pm
Portfolio Pulse from Benzinga Insights
January 05, 2024 | 9:31 pm
Portfolio Pulse from Benzinga Newsdesk
January 05, 2024 | 1:32 pm
Portfolio Pulse from Avi Kapoor
December 26, 2023 | 6:48 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.